Mimedx (MDXG) Change in Taxes (2016 - 2017)

Mimedx (MDXG) reported Change in Taxes of -$2.2 million for Q4 2017, down 184.22% on a YoY basis from $2.6 million in Q4 2016, and down 168.94% sequentially from $3.2 million in Q3 2017.

Mimedx (MDXG) Change in Taxes (2016 - 2017) Analysis & Trends

Mimedx (MDXG) has 2 years of Change in Taxes data on file, last reported at -$2.2 million in Q4 2017.

  • For the quarter ending Q4 2017, Change in Taxes fell 184.22% year-over-year to -$2.2 million; the trailing twelve-month figure through Mar 2020 stood at -$2.2 million (up 71.71% YoY), and the FY2017 full-year result was -$5.6 million, down 207.88% from the prior year.
  • Change in Taxes slipped to -$2.2 million in Q4 2017, from $3.2 million in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $3.2 million in Q3 2017 to a low of -$8.7 million in Q2 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -8,939.03
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Mimedx 615.09 Mn 455.31 Mn 41.62 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2017 -2.17 Mn
Dec 31, 2017 -2.17 Mn
Sep 30, 2017 3.15 Mn
Sep 30, 2017 3.15 Mn
Jun 30, 2017 -8.66 Mn
Jun 30, 2017 -8.66 Mn
Mar 31, 2017 2.07 Mn
Mar 31, 2017 2.07 Mn
Dec 31, 2016 2.58 Mn
Dec 31, 2016 2.58 Mn
Sep 30, 2016 1.23 Mn
Sep 30, 2016 1.23 Mn
Jun 30, 2016 977,000.00
Jun 30, 2016 977,000.00
Mar 31, 2016 411,000.00
Mar 31, 2016 411,000.00